Polycystic ovary syndrome: the present position

References

• Conway G. S., Jacobs H. S. Clinical implications of hyperinsulinaemia in women. Clin. Endocrinol. 1993; 39: 623–32
   PubMed Web of Science ®Google Scholar
• Conway G. S., Jacobs H. S. Acanthosis nigricans in obese women with polycystic ovary syndrome: disease spectrum, not distinct entity. Postgrad. Med. J. 1990; 66: 536–8
   PubMed Web of Science ®Google Scholar
• Dunaif A., Segbal K. R., Shelley D. R., Green G., Dobrjansky A., Licholai T. Evidence for distinctive and intrinsic defects in insulin action in the polycystic ovary syndrome. Diabetes 1992; 41: 1257–66
   PubMed Web of Science ®Google Scholar
• Dunaif A., Xia J., Book C.-B., Schenker E., Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest. 1995; 96: 801–10
   PubMed Web of Science ®Google Scholar
• Zhang L.-H., Rodriguez H., Ohno S., Miller W. L. Serine phosphorylation of human P450c 17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA 1995; 92: 10619–23
   PubMed Web of Science ®Google Scholar
• Scott J. New chapter for the fat controller. Nature (London) 1996; 379: 113–14
   PubMed Web of Science ®Google Scholar
• Chehab F. F., Lim M. E., Ronghua L. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 1996; 12: 318–20
   PubMed Web of Science ®Google Scholar
• Stephens T. W., Basinski M., Bristow P. K. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature (London) 1995; 377: 530–2
   PubMed Web of Science ®Google Scholar
• Considene R. V., Sinha M. K., Heiman M. L. Serum immunoreactive leptin concentrations in normal weight and obese humans. N. Engl. J. Med. 1996; 334: 292–5
   PubMed Web of Science ®Google Scholar
• McCluskey S., Evans C., Lacey J. H., Pearce J. M., Jacobs H. S. Polycystic ovary syndrome and bulimia. Fertil. Steril. 1991; 55: 287–91
   PubMed Web of Science ®Google Scholar
• Conway G. S., Jacobs H. S., Holly J. M. P., Wass J. A. S. Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor-small binding protein in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 1990; 33: 593–603
   PubMed Web of Science ®Google Scholar
• Reaven G. M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
   PubMed Web of Science ®Google Scholar
• Conway G. S., Agrawal R., Betteridge D. J., Jacobs H. S. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin. Endocrinol. 1992; 37: 119–26
   PubMed Web of Science ®Google Scholar
• Dahlgren E., Johansson S., Linstedt G., Knutson F., Oden A., Janson P.-O., Mattson L. A., Crona N., Lundberg P. A. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil. Steril. 1992; 57: 505–13
   PubMed Web of Science ®Google Scholar
• Wild R. A. Obesity, lipids, cardiovascular ed. 1995; 98(1A)27S–32S
   Google Scholar
• Dahlgren E., Janson P.-O., Johansson S., Lapidus L., Oden A. Polycystic ovary syndrome and the risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet. Gynecol. Scand. 1992; 71: 599–604
   PubMed Web of Science ®Google Scholar
• DiCarlo C., Shoham Z., MacDougal J., Patel A., Hall M., Jacobs H. S. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil. Steril. 1992; 57: 314–19
   PubMed Web of Science ®Google Scholar
• Dahlgren E., Janson P.-O., Johansson T., Lapidus L., Linstedt G., Tengborn L. Haemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil. Steril. 1994; 61: 455–60
   PubMed Web of Science ®Google Scholar
• Donesky B. W., Adashi E. Y. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil. Steril. 1995; 63: 439–63
   PubMed Web of Science ®Google Scholar
• Stein I. F. Ultimate results of bilateral ovarian wedge resection: twenty-five years follow-up. Int. J. Fertil. 1956; 1: 333–44
   Google Scholar
• Neuwirth R. S. A method of bilateral ovarian biopsy at laparoscopy in infertility and chronic anovulation. Fertil. Steril. 1972; 23: 361–6
   PubMed Web of Science ®Google Scholar
• Gjønnsess H. Polycystic ovary syndrome treated by electrocautery through the laparoscope. Fertil. Steril. 1984; 41: 20–5
   PubMed Web of Science ®Google Scholar
• Darnell K. F., Miller W. Polycystic ovaries treated by laser vaporization. Fertil. Steril. 1989; 51: 232–6
   PubMed Web of Science ®Google Scholar
• Kojima E., Yanagibon A., Otaka K., Hirakawa S. Ovarian wedge resection with contact Nd:Yag laser irradiation used laparoscopically. J. Reprod. Med. 1989; 34: 444–6
   PubMed Web of Science ®Google Scholar
• Armar N. A., McGarrigle H. H. G., Honour J. W., Holownia P., Jacobs H. S., Lachelin G. C. L. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil. Steril. 1990; 53: 45–9
   PubMed Web of Science ®Google Scholar
• Donesky B. W., Adashi E. Y. Surgical ovulation induction: the role of ovarian diathermy in polycystic ovary syndrome. Baill. Clin. Endocrinol. Metab. 1996; 10: 293–310
   PubMed Web of Science ®Google Scholar
• Armar N. A., Lachelin G. C. L. Laparoscopic ovarian diathermy: an effective treatment for anti-oestrogen resistant anovulatory infertility in women with the polycystic ovary syndrome. Br. J. Obstet. Gynaecol. 1993; 100: 161–4
   PubMedGoogle Scholar
• Farhi J., Soule S., Jacobs H. S. Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil. Steril. 1995; 64: 930–5
   PubMed Web of Science ®Google Scholar
• Balen A. H., Tan S. L., Jacobs H. S. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br. J. Obstet. Gynaecol. 1993; 100: 1082–9
   PubMedGoogle Scholar
• Adashi E. Y., Resmck C. E., D'Ercole A. J. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 1985; 6: 400–20
   PubMed Web of Science ®Google Scholar
• Balen A. H., Jacobs H. S. Gonadotrophin surge attenuating factor: a missing link in the control of LH secretion. Clin. Endocrinol. 1991; 35: 399–402
   PubMed Web of Science ®Google Scholar
• Balen A. H., Jacobs H. S. A prospective study comparing ulilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil. Steril. 1994; 62: 921–5
   PubMed Web of Science ®Google Scholar
• Farhi J., West C., Patel A., Jacobs H. S. Treatment of anovulatory infertility: the problem of multiple pregnancy. Hum. Reprod. 1996; 11: 429–34
   PubMed Web of Science ®Google Scholar
• Gjønnæss H. Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting results. Acta Obstet. Gynecol. Scand. 1994; 73: 1–5
   Web of Science ®Google Scholar
• Regan L., Owen E. J., Jacobs H. S. Hypersecretion of LH, infertility and spontaneous abortion. Lancet 1990; 336: 1141–2
   PubMed Web of Science ®Google Scholar